| Efficacy of tocilizumab in patients hospitalized with Covid-19 JH Stone, MJ Frigault, NJ Serling-Boyd, AD Fernandes, L Harvey, ... New England Journal of Medicine 383 (24), 2333-2344, 2020 | 1552 | 2020 |
| Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis P Domingo, I Mur, GM Mateo, M del Mar Gutierrez, V Pomar, N de Benito, ... Jama 326 (6), 499-518, 2021 | 526 | 2021 |
| Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody … M Sagar, X Wu, S Lee, J Overbaugh Journal of virology 80 (19), 9586-9598, 2006 | 384 | 2006 |
| Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and … B Chohan, D Lang, M Sagar, B Korber, L Lavreys, B Richardson, ... Journal of virology 79 (10), 6528-6531, 2005 | 343 | 2005 |
| Recent endemic coronavirus infection is associated with less-severe COVID-19 M Sagar, K Reifler, M Rossi, NS Miller, P Sinha, LF White, JP Mizgerd The Journal of clinical investigation 131 (1), 2021 | 339 | 2021 |
| Long-term reduction in peripheral blood HIV type 1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation TJ Henrich, Z Hu, JZ Li, G Sciaranghella, MP Busch, SM Keating, ... The Journal of infectious diseases 207 (11), 1694-1702, 2013 | 328 | 2013 |
| Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor–sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized … JL Lennox, RJ Landovitz, HJ Ribaudo, I Ofotokun, LH Na, C Godfrey, ... Annals of internal medicine 161 (7), 461-471, 2014 | 318 | 2014 |
| Effect of canakinumab vs placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19: a randomized clinical trial R Caricchio, A Abbate, I Gordeev, J Meng, PY Hsue, T Neogi, R Arduino, ... Jama 326 (3), 230-239, 2021 | 175 | 2021 |
| Transmission of Histoplasma capsulatum by Organ Transplantation AP Limaye, PA Connolly, M Sagar, TR Fritsche, BT Cookson, LJ Wheat, ... New England Journal of Medicine 343 (16), 1163-1166, 2000 | 170 | 2000 |
| p53 and tumor necrosis factor α regulate the expression of a mitochondrial chloride channel protein E Fernández-Salas, M Sagar, C Cheng, SH Yuspa, WC Weinberg Journal of Biological Chemistry 274 (51), 36488-36497, 1999 | 169 | 1999 |
| Selection of HIV variants with signature genotypic characteristics during heterosexual transmission M Sagar, O Laeyendecker, S Lee, J Gamiel, MJ Wawer, RH Gray, ... The Journal of infectious diseases 199 (4), 580-589, 2009 | 155 | 2009 |
| Infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression M Sagar, L Lavreys, JM Baeten, BA Richardson, K Mandaliya, ... Journal of virology 77 (23), 12921-12926, 2003 | 154 | 2003 |
| In vivo emergence of vicriviroc resistance in a human immunodeficiency virus type 1 subtype C-infected subject AMN Tsibris, M Sagar, RM Gulick, Z Su, M Hughes, W Greaves, ... Journal of virology 82 (16), 8210-8214, 2008 | 132 | 2008 |
| Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population M Sagar, L Lavreys, JM Baeten, BA Richardson, K Mandaliya, ... Aids 18 (4), 615-619, 2004 | 121 | 2004 |
| In vivo fitness cost of the M184V mutation in multidrug-resistant human immunodeficiency virus type 1 in the absence of lamivudine R Paredes, M Sagar, VC Marconi, R Hoh, JN Martin, NT Parkin, ... Journal of virology 83 (4), 2038-2043, 2009 | 106 | 2009 |
| Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257 I Ofotokun, LH Na, RJ Landovitz, HJ Ribaudo, GA McComsey, C Godfrey, ... Clinical Infectious Diseases 60 (12), 1842-1851, 2015 | 100 | 2015 |
| Previously transmitted HIV-1 strains are preferentially selected during subsequent sexual transmissions AD Redd, AN Collinson-Streng, N Chatziandreou, CE Mullis, ... The Journal of infectious diseases 206 (9), 1433-1442, 2012 | 99 | 2012 |
| HIV-1 transmission biology: selection and characteristics of infecting viruses M Sagar The Journal of infectious diseases 202 (Supplement_2), S289-S296, 2010 | 93 | 2010 |
| Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes M Sagar, E Kirkegaard, EM Long, C Celum, S Buchbinder, ES Daar, ... Journal of virology 78 (13), 7279-7283, 2004 | 86 | 2004 |
| Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge P Sinha, A Mostaghim, CG Bielick, A McLaughlin, DH Hamer, LM Wetzler, ... International Journal of Infectious Diseases 99, 28-33, 2020 | 85 | 2020 |
Julie OverbaughProfessor在 fhcrc.org 的电子邮件经过验证
